Clinical Trials Logo

Opiate Addiction clinical trials

View clinical trials related to Opiate Addiction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02867124 Recruiting - Opiate Addiction Clinical Trials

Long-acting Naltrexone for Pre-release Prisoners

Start date: January 1, 2017
Phase: Phase 3
Study type: Interventional

This proposed five-year study will focus on whether the addition of providing XR-NTX treatment at a patients' place of residence will increase adherence and thus efficacy of the medication.Following initial screening, informed consent, and medical examination, pre-release prisoners at each facility will be block randomized (N=240) within gender to either: Condition 1. XR-NTX-OTx (n=120): One injection of XR-NTX in prison, followed by six monthly injections post-release in the community at an opioid treatment program; or Condition 2. XR-NTX+MMTx (n=120): One injection of XR-NTX in prison, followed by six monthly injections post-release in the community at the patient's place of residence.

NCT ID: NCT02440152 Recruiting - Opiate Addiction Clinical Trials

The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention

Start date: February 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The nucleus accumbens (NAcc) has a significant role in the process of opiate addiction and the initiation of relapse after detoxification. There is evidence that deep brain stimulation (DBS) of the NAcc exerts a positive effect on individuals with severe heroin addiction via inhibitory action . The investigators hypothesise that bilateral stimulation of the NAcc will significantly reduce withdrawal symptoms and thus enable the patients to substantially decrease their Levomethadone usage.

NCT ID: NCT01934751 Recruiting - Opiate Addiction Clinical Trials

Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction

H-SOAP
Start date: September 2013
Phase: N/A
Study type: Interventional

Hypothesis: Patients who are addicted to opioids or alcohol will have reduced substance use, health care utilization if they have immediate and convenient access to pharmacotherapy and addiction counselling. Summary: This randomized trial will compare two different interventions for 124 alcohol and opioid-addicted patients admitted to either Women's Own Detox (WOD) at the University Health Network or the Withdrawal Management Service (WMS) at Saint Michael's Hospital (SMH. The Delayed Intervention group will receive a card with contact information for the St. Michael's Hospital and Women's College Hospital addiction medicine services. The Rapid Intervention group will be seen by an addiction physician from one of these services, within a day or two of their admission to the WOD or the SMH WMS. The addiction physician will prescribe buprenorphine or anti-alcohol medications, and the physician, nurse and/or therapist will provide ongoing counseling, follow-up and shared care with the family physician. Outcomes (measured at 6 and 12 months) include treatment retention, health care utilization and cost, medications prescribed, and alcohol and opioid use.